Key Documents
Thomas Quertermous, MD
- Professor, Medicine - Cardiovascular Medicine
Contact Information
- Clinical Offices
Cardiovascular Medicine Clinic 300 Pasteur Dr A260 MC 5319 Stanford, CA 94305-2200 Telephone Work (650) 723-5012 Fax (650) 725-2178CVRB #269, MC: 5406 Stanford, CA 94305 Telephone Work (650) 723-5013 Fax (650) 725-2178
- Academic Offices
Personal Information Tel (650) 723-5013Administrative Contact Celest Landini Administrative Assistant Email clandini@cvmed.stanford.edu Tel Work 650-723-5013
Postdoctoral Advisees
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities.
- Consulting: Aviir, Incorporated, Via Pharmaceuticals
- Equity: Via Pharmaceuticals
- Service on Board of Directors: Aviir, Incorporated
Research Interests
The Quertermous laboratory employs two basic approaches of study to better understand the genetic basis of atherosclerotic heart disease. One approach uses basic molecular biology methodology, primarily working with cellular and genetic mouse models, and is focused on the recently identified apelin-APJ pathway. A second approach employs the power of modern human genetics. Informative cohorts have been collected that allow investigation of risk factors such as hypertension and insulin resistance as well as coronary heart disease. Initial studies have employed the candidate gene approach, and more recently whole genome association studies, to identify allelic variation that is associated with risk factor and disease susceptibility.
Clinical Trials
Publications
- Am J Physiol Heart Circ Physiol. 2009; (5): H1329-35
- Hum Mol Genet. 2009; (11): 2091-8
- J Atheroscler Thromb. 2009; (4): 327-38
- Am Heart J. 2009; (5): 939-45
- Proc Natl Acad Sci U S A. 2009; (20): 8227-32
- Regul Pept. 2009; (1-3): 32-9
- Stem Cells. 2009; (3): 653-61
- Am J Physiol Lung Cell Mol Physiol. 2009; (4): L594-602
- Am J Hypertens. 2008; (4): 471-6
- Hum Genet. 2008; (4): 399-408
- Atherosclerosis. 2008; (1): 136-44
- Am J Physiol Heart Circ Physiol. 2008; (1): H88-98
- J Surg Res. 2008; (1): 73-80
- BMC Med Genet. 2008; 23
- Hum Mol Genet. 2008; (15): 2320-8
- Diabetes Res Clin Pract. 2008; (2): 231-7
- ILAR J. 2008; E1-7
- Am J Physiol Heart Circ Physiol. 2008; (3): H1351-H1368
- J Clin Invest. 2008; (10): 3343-54
- Arterioscler Thromb Vasc Biol. 2008; (10): 1687-8
- Science. 2008; (5904): 1101-4
- PLoS One. 2008; (7): e2609
- Arterioscler Thromb Vasc Biol. 2007; (10): 2068-78
- Am J Physiol Endocrinol Metab. 2007; (6): E1590-6
- Am Heart J. 2007; (6): 1035-42
- Am Heart J. 2007; (6): 1043-51
- Am Heart J. 2007; (6): 1052-8
- Am Heart J. 2007; (6): 1059-64
- J Am Soc Nephrol. 2007; (11): 2853-62
- Physiol Genomics. 2007; (3): 402-9
- J Atheroscler Thromb. 2007; (4): 192-201
- Cell Metab. 2007; (2): 129-36
- Diabetologia. 2007; (8): 1631-40
- J Hypertens. 2007; (5): 985-92
- Dev Cell. 2007; (3): 319-20
- Am J Hypertens. 2006; (1): 122-7
- Ann Intern Med. 2006; (4): 229-38
- Physiol Genomics. 2006; (2): 194-202
- Circ Res. 2006; (2): 200-8
- Physiol Genomics. 2006; (1): 29-38
- Magn Reson Med. 2006; (1): 203-9
- Arterioscler Thromb Vasc Biol. 2006; (5): 1058-65
- Circ Res. 2006; (4): 424-33
- J Mol Cell Cardiol. 2006; (5): 778-81
- Circulation. 2006; (24): 2644-54
- J Am Coll Cardiol. 2006; (9): 1800-7
- Eur J Hum Genet. 2006; (4): 469-77
- Diabetes. 2005; (3): 909-14
- Cardiovasc Res. 2005; (3): 594-600
- Anat Rec A Discov Mol Cell Evol Biol. 2005; (2): 1165-75
- Hypertension. 2005; (4): 751-7
- Nat Genet. 2005; (2): 177-81
- Nutr Metab (Lond). 2005; 17
- Dev Biol. 2005; (2): 595-611
- Am J Hum Genet. 2005; (2): 268-75
- Physiol Genomics. 2005; (2): 213-26
- J Biol Chem. 2005; (26): 24680-9
- Cardiovasc Res. 2005; (1): 73-82
- Arterioscler Thromb Vasc Biol. 2005; (2): 302-8
- J Heart Lung Transplant. 2005; (6): 737-44
- Physiol Genomics. 2005; (1): 103-18
- Diabetes. 2005; (4): 1200-6
- Physiol Genomics. 2004; (3): 292-302
- J Biol Chem. 2004; (43): 45085-92
- J Lipid Res. 2004; (9): 1614-23
- Circulation. 2004; (10): 1314-9
- Genomics. 2004; (1): 24-33
- J Mol Cell Cardiol. 2004; (6): 1159-70
- J Biol Chem. 2004; (53): 55315-23
- Blood Press. 2004; (6): 355-61
- J Clin Endocrinol Metab. 2004; (11): 5772-8
- J Biol Chem. 2004; (52): 54032-8
- Proc Natl Acad Sci U S A. 2004; (29): 10529-34
- Circ Res. 2003; (12): 1193-201
- Ann Thorac Surg. 2003; (4): 1246-51
- J Hum Hypertens. 2003; (3): 193-8
- J Mol Cell Cardiol. 2003; (4): 421-5
- Cardiovasc Res. 2003; (3): 647-54
- Diabetologia. 2003; (7): 977-83
- J Clin Invest. 2003; (1): 30-41
- Lymphat Res Biol. 2003; (2): 133-45
- J Clin Invest. 2003; (3): 347-55
- Physiol Genomics. 2003; (3): 249-62
- J Biol Chem. 2003; (36): 34598-604
- Circulation. 2003; (12): 1432-9
- Am J Physiol Heart Circ Physiol. 2002; (5): H1924-32
- Physiol Genomics. 2002; (2): 99-107
- Microvasc Res. 2002; (1): 148-61
- FASEB J. 2002; (14): 1985-7
- J Lipid Res. 2002; (11): 1763-9
- J Biol Chem. 2001; (19): 16223-31
- Curr Protoc Mol Biol. 2001; Unit5.4
- Curr Protoc Mol Biol. 2001; Unit5.7
- Curr Protoc Mol Biol. 2001; Unit6.1
- Curr Protoc Mol Biol. 2001; Unit5.3
- Curr Protoc Mol Biol. 2001; Unit6.5
- Biochem J. 2001; (Pt 1): 23-9
- Am J Physiol Cell Physiol. 2001; (5): C1422-33
- J Biol Chem. 2001; (42): 39197-205
- Circ Res. 2000; (10): 1024-30
- Biochem Biophys Res Commun. 2000; (1): 90-3
- J Cardiovasc Pharmacol. 2000; (4 Suppl 2): S7-11
- J Biol Chem. 1999; (20): 14170-5
- J Biol Chem. 1999; (29): 20376-83
- J Biol Chem. 1999; (16): 11101-9
- J Clin Invest. 1998; (6): 1389-97
- Mech Dev. 1998; (1): 33-43
- Biochem J. 1998; 335-43
- Genes Dev. 1998; (1): 21-33
- J Biol Chem. 1997; (51): 32613-22
- J Clin Invest. 1997; (6): 1380-9
- Heart Vessels. 1997; (6): 255-61
- J Cardiovasc Pharmacol. 1996; (6): 774-83
- J Am Coll Cardiol. 1996; (5): 1286-91
- Genomics. 1995; (3): 598-601
- Proc Natl Acad Sci U S A. 1995; (19): 8763-7
- J Histochem Cytochem. 1995; (2): 203-9
- Mol Cell Biol. 1995; (8): 4225-31
- Stem Cells. 1995; (5): 541-7
- Clin Immunol Immunopathol. 1994; (3): 380-9
- J Surg Res. 1994; (2): 280-3
- Proc Natl Acad Sci U S A. 1994; (15): 7066-70
- J Hypertens. 1994; (6): 643-51
- J Biol Chem. 1993; (31): 23000-7
- Biochemistry. 1993; (31): 7932-8
- Thromb Res. 1993; (2): 221-9
- J Biol Chem. 1992; (21): 14519-22
- J Biol Chem. 1992; (31): 22694
- J Biol Chem. 1992; (34): 24892-6
- J Biol Chem. 1992; (14): 9467-9
- J Biol Chem. 1991; (34): 23251-6
- Proc Natl Acad Sci U S A. 1991; (22): 10337-41
- Mol Biol Med. 1991; (2): 245-55
- Genomics. 1991; (1): 236-42
- Blood. 1991; (4): 1005-18
- J Biol Chem. 1991; (24): 16188-92
- J Biol Chem. 1991; (28): 19034-9
- J Clin Invest. 1990; (1): 141-7
- FEBS Lett. 1990; (1-2): 207-13
- J Biol Chem. 1990; (5): 2569-75
- Jpn Circ J. 1990; (4): 345-53
- J Biol Chem. 1990; (18): 10446-50
- Circulation. 1989; (2): 217-24
- Science. 1989; (4887): 51-6
- In Vitro Cell Dev Biol. 1989; (3 Pt 1): 289-92
- J Biol Chem. 1989; (18): 10851-7
- Blood. 1989; (1): 222-8
- J Immunol. 1989; (3): 890-5
- J Biol Chem. 1989; (30): 18156-61
- Methods Enzymol. 1989; 515-27
- Blood. 1988; (5): 1833-6
- Arthritis Rheum. 1988; (11): 1371-6
- Clin Res. 1988; (5): 501-6
- Arch Intern Med. 1988; (4): 882-5
- Immunogenetics. 1988; (4): 231-8
- Proc Natl Acad Sci U S A. 1987; (19): 6904-8
- J Immunol. 1987; (4): 1260-9
- J Immunol. 1987; (6): 1724-9
- J Immunol. 1987; (8): 2687-90
- Proc Natl Acad Sci U S A. 1987; (13): 4547-51
- Science. 1987; (4819): 1217-9
- Nature. 1986 Jul 10-16; (6075): 184-7
- Am J Cardiol. 1986; (4): 322-6
- Science. 1986; (4735): 252-5
- Proc Natl Acad Sci U S A. 1986; (22): 8759-63
- J Immunol. 1986; (6): 2043-9
- Blood. 1986; (4): 914-8
- Proc Natl Acad Sci U S A. 1986; (8): 2619-23
- Radiology. 1983; (1): 257-8